Brainstorm Cell Therapeut...

NASDAQ: BCLI · Real-Time Price · USD
0.63
0.03 (5.00%)
At close: Aug 15, 2025, 3:47 PM
0.61
-2.38%
After-hours: Aug 15, 2025, 03:47 PM EDT

Brainstorm Cell Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
1.04 -0.92 -2.48 -5.95
PEG Ratio
-0.01 0.02 1.56 0.21
PS Ratio
14.20 n/a n/a n/a
PB Ratio
-1.55 -3.24 -19.95 7.52
P/FCF Ratio
-1.33 -768.71 -3.11 -5.47
P/OCF Ratio
-1.33 -0.77 -3.11 -5.54
OCF/S Ratio
-10.71 n/a n/a n/a
Debt / Equity Ratio
-0.09 -0.14 -1.36 0.26
Quick Ratio
0.04 0.24 0.35 3.69
Current Ratio
0.04 0.24 0.35 3.69
Asset Turnover
0.46 n/a n/a n/a
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-1.5 3.54 8.05 -1.26
Return on Assets
6.34 -4.09 -2.87 -0.84
Return on Invested Capital
n/a 5.97 -23.03 -1
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 n/a n/a n/a
Net Profit Margin
13.69 n/a n/a n/a
Pretax Profit Margin
13.69 n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a